APC2 and cancer: Western blot analysis confirmed that UNC0638 treatment dramatically reduced the level of H3K9Me2, increased the levels of APC2, DKK1, and WIF1 proteins, and resulted in decreased β-catenin in these cancer cells (Fig. 5b).